Omega-3 fatty acids, energy substrates, and brain function during aging.

The maintenance of optimal cognitive function is a central feature of healthy aging. Impairment in brain glucose uptake is common in aging associated cognitive deterioration, but little is known of how this problem arises or whether it can be corrected or bypassed. Several aspects of the challenge to providing the brain with an adequate supply of fuel during aging seem to relate to omega-3 fatty acids. For instance, low intake of omega-3 fatty acids, especially docosahexaenoic acid (DHA), is becoming increasingly associated with several forms of cognitive decline in the elderly, particularly Alzheimer's disease. Brain DHA level seems to be an important regulator of brain glucose uptake, possibly by affecting the activity of some but not all the glucose transporters. DHA synthesis from either alpha-linolenic acid (ALA) or eicosapentaenoic acid (EPA) is very low in humans begging the question of whether these DHA precursors are likely to be helpful in maintaining cognition during aging. We speculate that ALA and EPA may well have useful supporting roles in maintaining brain function during aging but not by their conversion to DHA. ALA is an efficient ketogenic fatty acid, while EPA promotes fatty acid oxidation. By helping to produce ketone bodies, the effects of ALA and EPA could well be useful in strategies intended to use ketones to bypass problems of impaired glucose access to the brain during aging. Hence, it may be time to consider whether the main omega-3 fatty acids have distinct but complementary roles in brain function.

[1]  Mark S. Cohen,et al.  Patterns of brain activation in people at risk for Alzheimer's disease. , 2000, The New England journal of medicine.

[2]  D. Williamson,et al.  Physiological roles of ketone bodies as substrates and signals in mammalian tissues. , 1980, Physiological reviews.

[3]  M. Vranic,et al.  Fuel Homeostasis and the Nervous System , 2012, Advances in Experimental Medicine and Biology.

[4]  M. Reger,et al.  Effects of β-hydroxybutyrate on cognition in memory-impaired adults , 2004, Neurobiology of Aging.

[5]  M. Tierney,et al.  Fatty acid analysis of blood plasma of patients with alzheimer's disease, other types of dementia, and cognitive impairment , 2000, Lipids.

[6]  J. Lindsay,et al.  Omega-3 fatty acids and risk of cognitive impairment and dementia. , 2003, Journal of Alzheimer's disease : JAD.

[7]  L. Sokoloff,et al.  Measurement of local cerebral glucose utilization and its relation to local functional activity in the brain. , 1991, Advances in experimental medicine and biology.

[8]  T. Dolecek,et al.  Epidemiological Evidence of Relationships between Dietary Polyunsaturated Fatty Acids and Mortality in the Multiple Risk Factor Intervention Trial , 1992, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[9]  D. Loewenstein,et al.  Viability of Neocortical Function Shown in Behavioral Activation State PET Studies in Alzheimer Disease , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[10]  H. Tuokko,et al.  The effect of improved glycemic control on cognitive functions in the elderly patient with diabetes. , 1993, Journal of gerontology.

[11]  L. Thompson,et al.  Dietary sources and metabolism of α-linolenic acid. , 2003 .

[12]  J. Edmond Ketone bodies as precursors of sterols and fatty acids in the developing rat. , 1974, The Journal of biological chemistry.

[13]  D. Bennett,et al.  Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. , 2003, Archives of neurology.

[14]  B. Heude,et al.  Cognitive decline and fatty acid composition of erythrocyte membranes--The EVA Study. , 2003, The American journal of clinical nutrition.

[15]  F. Pifferi,et al.  (n-3) polyunsaturated fatty acid deficiency reduces the expression of both isoforms of the brain glucose transporter GLUT1 in rats. , 2005, The Journal of nutrition.

[16]  Kazunori Sato,et al.  Effect of β-Hydroxybutyrate, a Cerebral Function Improving Agent, on Cerebral Hypoxia, Anoxia and Ischemia in Mice and Rats , 2001 .

[17]  Douglas L. Rothman,et al.  Mitochondrial Dysfunction in the Elderly: Possible Role in Insulin Resistance , 2003, Science.

[18]  B. Lawlor,et al.  Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case–control study , 2003, British Journal of Nutrition.

[19]  W. Burnham,et al.  Dietary Fat, Ketosis, and Seizure Resistance in Rats on the Ketogenic Diet , 2000, Epilepsia.

[20]  P. Ferré,et al.  Ketone body transport in the human neonate and infant. , 1986, The Journal of clinical investigation.

[21]  L. Thompson,et al.  Flaxseed in Human Nutrition , 1995 .

[22]  N. Balak,et al.  Costs of disorders of the brain in Europe , 2007, European journal of neurology.

[23]  G F Cahill,et al.  Brain metabolism during fasting. , 1967, The Journal of clinical investigation.

[24]  K. Kristensson,et al.  Fatty acid composition of brain phospholipids in aging and in Alzheimer’s disease , 1991, Lipids.

[25]  Jean-François Dartigues,et al.  Fish, meat, and risk of dementia: cohort study , 2002, BMJ : British Medical Journal.

[26]  A. Hofman,et al.  Dietary fat intake and the risk of incident dementia in the Rotterdam study , 1997, Annals of neurology.

[27]  R N Kalaria,et al.  Reduced Glucose Transporter at the Blood‐Brain Barrier and in Cerebral Cortex in Alzheimer Disease , 1989, Journal of neurochemistry.

[28]  S. Amiel,et al.  Ketone infusion lowers hormonal responses to hypoglycaemia: evidence for acute cerebral utilization of a non-glucose fuel. , 1991, Clinical science.

[29]  S. Vermunt,et al.  Effects of age and dietary n-3 fatty acids on the metabolism of [13C]-α-linolenic acid , 2007, Lipids.

[30]  Denis A. Evans,et al.  Fish consumption and cognitive decline with age in a large community study. , 2005, Archives of neurology.

[31]  A. A. Spector,et al.  Eicosapentaenoic acid metabolism in brain microvessel endothelium: effect on prostaglandin formation. , 1989, Journal of lipid research.

[32]  D. Horrobin,et al.  Ethyl-EPA in Alzheimer's disease--a pilot study. , 2004, Prostaglandins, leukotrienes, and essential fatty acids.

[33]  R. Bazinet,et al.  Why is carbon from some polyunsaturates extensively recycled into lipid synthesis? , 2003, Lipids.

[34]  P. Cryer,et al.  Effect of Hyperketonemia and Hyperlacticacidemia on Symptoms, Cognitive Dysfunction, and Counterregulatory Hormone Responses During Hypoglycemia in Normal Humans , 1994, Diabetes.

[35]  Brennan Jt Efficiency of conversion of alpha-linolenic acid to long chain n-3 fatty acids in man. , 2002 .

[36]  J. Hibbeln,et al.  Physiological compartmental analysis of !-linolenic acid metabolism in adult humans , 2013 .

[37]  J. Downing,et al.  Dietary n-3 and n-6 fatty acids alter avian glucose metabolism , 2005, British poultry science.

[38]  G. Mitchell,et al.  Pathways and control of ketone body metabolism: on the fringe of lipid biochemistry. , 2004, Prostaglandins, leukotrienes, and essential fatty acids.

[39]  W. Grant Dietary Links to Alzheimer's Disease , 1997 .

[40]  A. Morris,et al.  Cerebral ketone body metabolism , 2005, Journal of Inherited Metabolic Disease.

[41]  J. Freeman,et al.  The Ketogenic Diet: A Treatment for Epilepsy , 2000 .

[42]  P. Shekelle,et al.  Effects of omega-3 fatty acids on cognitive function with aging, dementia, and neurological diseases. , 2005, Evidence report/technology assessment.

[43]  Stephen C Cunnane,et al.  Breath acetone predicts plasma ketone bodies in children with epilepsy on a ketogenic diet. , 2006, Nutrition.

[44]  A. Muir,et al.  Flax: The genus Linum , 2003 .

[45]  S. Craft,et al.  Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer's disease. , 2004, European journal of pharmacology.

[46]  G. Alexander,et al.  Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[47]  M. Lavialle,et al.  Glucose transport and utilization are altered in the brain of rats deficient in n‐3 polyunsaturated fatty acids , 2002, Journal of neurochemistry.

[48]  A R Damasio,et al.  Quantitative computed tomographic analysis in the diagnosis of dementia. , 1983, Archives of neurology.

[49]  D. Chisholm,et al.  The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. , 1993, The New England journal of medicine.

[50]  L. Cleland,et al.  Metabolism of stearidonic acid in human subjects: comparison with the metabolism of other n-3 fatty acids. , 2003, The American journal of clinical nutrition.

[51]  M. Patel,et al.  DEVELOPMENT AND REGULATION OF LIPID SYNTHESIS FROM KETONE BODIES BY RAT BRAIN , 1977, Journal of neurochemistry.

[52]  Y. Katayama,et al.  Effect of long-term administration of ethyl eicosapentate (EPA-E) on local cerebral blood flow and glucose utilization in stroke-prone spontaneously hypertensive rats (SHRSP) , 1997, Brain Research.

[53]  M. Kekomäki,et al.  OXIDATION OF GLUCOSE and D‐B‐OH‐BUTYRATE BY THE EARLY HUMAN FETAL BRAIN , 1975, Acta paediatrica Scandinavica.

[54]  P. Kris-Etherton,et al.  Dietary α-Linolenic Acid Reduces Inflammatory and Lipid Cardiovascular Risk Factors in Hypercholesterolemic Men and Women , 2004 .

[55]  P. Pencharz,et al.  A comparison of the metabolism of eighteen-carbon 13C-unsaturated fatty acids in healthy women Published, JLR Papers in Press, December 16, 2003. DOI 10.1194/jlr.M300304-JLR200 , 2004, Journal of Lipid Research.

[56]  M. Laville,et al.  Eicosapentaenoic acid induces mRNA expression of peroxisome proliferator-activated receptor gamma. , 2002, Obesity research.

[57]  K. Heininger, The cerebral glucose-fatty acid cycle: evolutionary roots, regulation, and (patho)physiological importance. , 2002, International review of neurobiology.

[58]  T. Montine,et al.  Fatty acid oxidation in the pathogenesis of Alzheimer's disease. , 2005, The American journal of pathology.

[59]  I. Skoog Detection of preclinical Alzheimer's disease. , 2000, The New England journal of medicine.

[60]  N. Foster,et al.  Alzheimer's disease , 1983, Neurology.

[61]  J. Olesen,et al.  Cost of disorders of the brain in Europe , 2005, European journal of neurology.

[62]  S. Stone-Elander,et al.  Effect of acute hyperketonemia on the cerebral uptake of ketone bodies in nondiabetic subjects and IDDM patients. , 2002, American journal of physiology. Endocrinology and metabolism.

[63]  G. Alexander,et al.  Correlations between apolipoprotein E ε4 gene dose and brain-imaging measurements of regional hypometabolism , 2005 .

[64]  S. Stone-Elander,et al.  Use of R-beta-[1-11C]hydroxybutyrate in PET studies of regional cerebral uptake of ketone bodies in humans. , 1995, The American journal of physiology.

[65]  L. Madsen,et al.  In contrast with docosahexaenoic acid, eicosapentaenoic acid and hypolipidaemic derivatives decrease hepatic synthesis and secretion of triacylglycerol by decreased diacylglycerol acyltransferase activity and stimulation of fatty acid oxidation. , 1999, The Biochemical journal.